下咽与食管多原发癌筛查诊治中国专家共识

Chinese expert consensus on multiple primary cancers of hypopharynx and esophagus

下咽癌与食管癌经常同时或异时发生,对高危人群进行多原发癌筛查、协同诊疗是改善患者预后的重要手段。目前国内尚无涉及这一交叉领域的筛查诊治规范。中国抗癌协会食管癌专业委员会发起并联合国内耳鼻咽喉头颈外科、放射肿瘤、消化内镜领域专家,组成中国下咽与食管癌协同诊疗工作组,通过文献回顾、经验推荐、专家讨论等多种形式,制定下咽与食管多原发癌筛查诊治共识;希望建立一个初步的临床诊疗建议,充分引起国内同道对于这一交叉领域的关注,通过规范化的临床实践,为将来高级别的循证医学指南的建立奠定基础。

Hypopharyngeal cancer and esophageal cancer often occur synchronously or metachronously.Timely screening,diagnosis and individual treatment are important to improve the prognosis of patients.At present,there is no clinical guideline or consensus in this cross-cutting area in China,and there is a need of consistent diagnosis and treatment recommendation for these patients.Under the sponsorship of the Committee of Esophageal Cancer in China Anti-Cancer Association,the Chinese Working Group on Cooperative Diagnosis and Treatment of Hypopharyngeal and Esophageal Cancer was established by domestic experts in the fields of otolaryngology head and neck surgery,radiation oncology,and gastrointestinal endoscopy.This consensus document on multiple primary cancers(simultaneous or metachronous)of the hypopharynx and esophagus was developed through literature review,collective experience and expert discussions.The goals of the consensus include:(1)raising concern for this cross-cutting field;(2)establishing a preliminary clinical diagnosis and treatment recommendation;(3)preparing for the establishment of future high-level guidelines through standardized clinical practice.